United States · Bill · S
S. 2208 (115th)
A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.
Introduced
7 December 2017
Last action
—
Status
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
14 January 2025
Summary
This bill directs the U.S. Postal Service to issue and sell an Alzheimer's Disease Research Semipostal Stamp. Proceeds from the sale of the stamp must be transferred to the National Institutes of Health for medical research relating to Alzheimer's disease. The stamp must be made available to the public for six years. Any limitation relating to whether more than one semipostal stamp may be offered for sale at the same time shall not apply to the stamp issued under this bill.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 7 December 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 7 December 2017
Introduced in Senate
summary · EN · 7 December 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/2208
- Open data entity: https://api.congress.gov/v3/bill/115/s/2208